Yousif Capital Management LLC Sells 782 Shares of Cushman & Wakefield plc (NYSE:CWK)

Yousif Capital Management LLC trimmed its holdings in shares of Cushman & Wakefield plc (NYSE:CWKFree Report) by 0.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 87,071 shares of the company’s stock after selling 782 shares during the quarter. Yousif Capital Management LLC’s holdings in Cushman & Wakefield were worth $1,139,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. XTX Topco Ltd increased its stake in shares of Cushman & Wakefield by 4.8% in the 3rd quarter. XTX Topco Ltd now owns 19,849 shares of the company’s stock worth $271,000 after purchasing an additional 903 shares in the last quarter. Blue Trust Inc. lifted its position in shares of Cushman & Wakefield by 26.5% during the 4th quarter. Blue Trust Inc. now owns 4,429 shares of the company’s stock valued at $60,000 after buying an additional 928 shares in the last quarter. Empowered Funds LLC grew its stake in shares of Cushman & Wakefield by 11.7% during the 3rd quarter. Empowered Funds LLC now owns 11,230 shares of the company’s stock valued at $153,000 after acquiring an additional 1,180 shares during the period. CIBC Asset Management Inc raised its stake in Cushman & Wakefield by 10.5% during the 3rd quarter. CIBC Asset Management Inc now owns 15,013 shares of the company’s stock worth $205,000 after acquiring an additional 1,421 shares during the period. Finally, KBC Group NV lifted its holdings in Cushman & Wakefield by 31.7% during the third quarter. KBC Group NV now owns 7,961 shares of the company’s stock valued at $109,000 after purchasing an additional 1,915 shares in the last quarter. 95.56% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on CWK shares. JPMorgan Chase & Co. increased their price target on Cushman & Wakefield from $14.00 to $17.00 and gave the stock a “neutral” rating in a research note on Monday, December 16th. The Goldman Sachs Group assumed coverage on Cushman & Wakefield in a research report on Friday, December 6th. They set a “sell” rating and a $15.00 target price for the company. Finally, Jefferies Financial Group downgraded Cushman & Wakefield from a “buy” rating to a “hold” rating and decreased their target price for the company from $18.00 to $14.00 in a research note on Thursday, January 2nd. One research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $15.50.

View Our Latest Stock Analysis on Cushman & Wakefield

Cushman & Wakefield Price Performance

Cushman & Wakefield stock opened at $12.92 on Friday. The firm’s fifty day moving average is $13.45 and its 200 day moving average is $13.41. Cushman & Wakefield plc has a 52-week low of $9.24 and a 52-week high of $16.11. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.76. The company has a market cap of $2.96 billion, a price-to-earnings ratio of 34.91 and a beta of 1.34.

Cushman & Wakefield Company Profile

(Free Report)

Cushman & Wakefield Plc engages in the provision of commercial real estate services. It operates through the following geographical segments: Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment consists of operations located in the United States, Canada and key markets in Latin America.

Recommended Stories

Institutional Ownership by Quarter for Cushman & Wakefield (NYSE:CWK)

Receive News & Ratings for Cushman & Wakefield Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cushman & Wakefield and related companies with MarketBeat.com's FREE daily email newsletter.